Applying Efficacy and Safety Science to Develop Individualized Treatment Plans for Patients With Multiple Sclerosis

Applying Efficacy and Safety Science to Develop Individualized Treatment Plans for Patients With Multiple Sclerosis is organized by AcademicCME.

Program Dates: June 28, 2019 - Sep 30, 2020.

Target Audience:
Neurologists, physicians, physician assistants, pharmacists, nurse practitioners, nurses, physical therapists and other healthcare professionals involved in the management of patients with multiple sclerosis

Accreditation:
• AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM.
• AcademicCME designates this enduring material for a maximum of 1.0 CNE contact hour (Provider number P0491).
• AcademicCME designates this continuing education activity for 1.0 CPE contact hour (0.10 CEU) of continuing pharmacy education credit (UAN

Program Overview:
Advances in the science and clinical trial data for the treatment of patients with multiple sclerosis (MS) continue to evolve at a rapid pace. This continuing education program, derived from content presented at the 2019 Consortium of Multiple Sclerosis Centers Meeting, will bring healthcare professionals up-to-date on recent treatment and management strategies in MS, including S1P based therapies. Emphasis will be placed on clinical decision making and best practices for utilizing personalized medicine to improve outcomes in patients with multiple sclerosis. This activity will address the important role of the interprofessional team in delivering optimal comprehensive care to patients with multiple sclerosis.

Learning Objectives:
• Update knowledge to the most current efficacy and safety data for MS therapies
• Develop MS therapeutic treatment plans on an individualized patient basis
• Integrate the interprofessional team to optimize patient education and adherence to therapy

Additional details will be posted as soon as information is available.